Alois Alzheimer on Presenile Dementia

@article{Tonkonogy1988AloisAO,
  title={Alois Alzheimer on Presenile Dementia},
  author={Joseph M. Tonkonogy and Gary S. Moak},
  journal={Journal of Geriatric Psychiatry and Neurology},
  year={1988},
  volume={1},
  pages={199 - 206}
}
  • J. Tonkonogy, G. Moak
  • Published 1 October 1988
  • Psychology, Medicine
  • Journal of Geriatric Psychiatry and Neurology
The work of Alois Alzheimer on presenile dementia is a landmark in the history of psychiatry not fully appreciated by contemporary psychiatrists. In this paper, the history of his landmark work is reviewed in the context of the growing importance of psychiatric involvement in Alzheimer's disease. Annotated excerpts from Alzheimer's second paper (1911), never before translated into English, are presented. The historical significance of Alzheimer's findings vis-a-vis Krae pelinian psychiatry and… Expand
Psychotic symptoms in Alzheimer's disease
Memory loss is the hallmark of Alzheimer' disease. However, psychotic symptoms have also been reported. We studied the prevalence of hallucinations and delusions in 677 subjects with probableExpand
Plaques and tangles in Alzheimer's disease
TLDR
It is found that the identification of the families in which an early-onset form of the disease behaves as a classic autosomal dominant trait eventually led to the discovery of the first mutation known to be associated with AD. Expand
Neuropathology for the Neuroradiologist: Plaques and Tangles
TLDR
The purpose of this report is to review the significance of plaques and neurofibrillary tangles in the context of Alzheimer disease. Expand
An Integrative Literature Review on the Nomenclature and Definition of Dementia at a Young Age.
TLDR
Despite relative consensus on the term young-onset dementia and an age at symptom onset being used as a cut-off criterion, much is still unclear concerning possible etiologies of dementia at a young age. Expand
Responsiveness of the QUALID to Improved Neuropsychiatric Symptoms in Patients with Alzheimer’s Disease
TLDR
While the QUALID correlates with behavioural measures at single time points, it does not appear to correlate with changes longitudinally associated with treatment. Expand
From transmitters to treatment: the pharmacotherapy of behavioural disturbances in dementia.
  • N. Herrmann, K. Lanctôt
  • Psychology, Medicine
  • Canadian journal of psychiatry. Revue canadienne de psychiatrie
  • 1997
TLDR
This paper reviews recent studies that examine the neurochemical basis of behavioural disturbances in dementia to determine whether transmitter-specific or behavioural-specific targeted interventions truly provide a rationale for the effective pharmacotherapy of these disorders. Expand
Recommendations for the Management of Behavioral and Psychological Symptoms of Dementia
  • N. Herrmann
  • Medicine
  • Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques
  • 2001
TLDR
The management of BPSD can significantly improve the quality of life for the patient and caregiver and pharmacotherapy must be monitored closely for both effectiveness and side effects, with consideration of medication withdrawal when appropriate. Expand

References

SHOWING 1-10 OF 47 REFERENCES
An overview of current concepts of Alzheimer's disease.
TLDR
The authors describe the clinical features of the various stages of Alzheimer’s disease and discuss the differential diagnosis, and describe the characteristic neuropathology and neurochemical abnormalities of the disease and their etiological implications. Expand
Dementia of the Alzheimer type. Clinical genetics, natural history, and associated conditions.
Relatives of 125 probands, who had dementia of the Alzheimer type as proved by autopsy, were subjects of a genetic investigation. The relatives exhibited an excess of dementing illness consistentExpand
Neuropsychological Features of Early and Late-Onset Alzheimer's Disease-Reply
In Reply. —Our study was undertaken primarily to test the hypothesis of Seltzer and Sherwin 1 regarding the greater degree of language impairment in younger patients with Alzheimer's disease (AD).Expand
A comparison of clinical features in early- and late-onset primary degenerative dementia. One entity or two?
TLDR
Findings indicate a degree of heterogeneity in the clinical features of patients with PDDAT and suggest a possible heightened selective vulnerability of the left hemisphere in early-onset cases, raising the possibility that the current view ofPDDAT as a unitary disorder may not be entirely valid. Expand
Molecular and Genetic Investigations on Alzheimer Brain Amyloid
TLDR
Current investigations have focused on the structure and properties of the amyloid protein, its corresponding messenger RNA, its cellular site of pro duction, and its chromosomal site of origin; these data are discussed in the present review. Expand
Clinical subtypes of dementia of the Alzheimer type
TLDR
Independent of duration of illness, myoclonus and noniatrogenic extrapyramidal disorder were associated with greater severity of dementia, and early onset was significantly associated with more prevalent and more severe language disorder. Expand
Neuropsychologic features of early- and late-onset Alzheimer's disease.
TLDR
Observations support the notion of left hemisphere vulnerability in early-onset Alzheimer's disease and can be interpreted as demonstrating the clinical variability of the illness rather than the necessity of dividing it into two distinct entities. Expand
Neuropsychological features of early and late-onset Alzheimer's disease.
TLDR
The authors interpreted their findings to mean that patients with onset of AD before age 65 years have more language impairment, and that those with onset at later ages have more impairment in visuoconstructive performance, but this conclusion is not warranted. Expand
Cortical somatostatin-like immunoreactivity in cases of Alzheimer's disease and senile Dementia of the Alzheimer type
TLDR
There were correlations between the extent of the reductions of ChAT activity and SLI concentration in four brain regions, and a greater reduction of parietal cortex SLI in younger patients than in the more elderly. Expand
Cortical Substance P‐Like Immunoreactivity in Cases of Alzheimer's Disease and Senile Dementia of the Alzheimer Type
TLDR
SPLI was significantly lower in five of eight regions in the patients with AD/SDAT and ChAT activity and SPLI in the parietal cortex of the presenile patients withADISDAT were not significantly different from values found in older patients. Expand
...
1
2
3
4
5
...